Local administration of ibandronate and bone morphogenetic protein-2 after ischemic osteonecrosis of the immature femoral head: A combined therapy that stimulates bone formation and decreases femoral head deformity

Journal of Bone and Joint Surgery

Volumn 93, Issue 10, 2011, Pages 905-913

  Vandermeer, Jacob S ^a   Kamiya, Nobuhiro ^a   Aya ay, James ^b   Garces, Amanda ^c   Browne, Richard ^a   Kim, Harry K W ^a  

^a TEXAS SCOTTISH RITE HOSPITAL FOR CHILDREN   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; IBANDRONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE RADIOGRAPHY; CONTROLLED STUDY; FEMUR HEAD; FEMUR HEAD NECROSIS; FEMUR MALFORMATION; HETEROTOPIC OSSIFICATION; HISTOLOGY; MALE; MONOTHERAPY; MORPHOMETRICS; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; PARAMETER; PRIORITY JOURNAL; TRABECULAR BONE;

EID: 79961048685     PISSN: 00219355     EISSN: 15351386     Source Type: Journal    
DOI: 10.2106/JBJS.J.00716     Document Type: Article

References (25)

1. Fleisch H. Bisphosphonates: mechanisms of action. Endocr Rev. 1998;19:80-100. (Pubitemid 29122075)
2. Astrand J, Aspenberg P. Systemic alendronate prevents resorption of necrotic bone during revascularization. A bone chamber study in rats. BMC Musculoskelet Disord. 2002;3:19.
3. Little DG, Peat RA, Mcevoy A, Williams PR, Smith EJ, Baldock PA. Zoledronic acid treatment results in retention of femoral head structure after traumatic osteonecrosis in young Wistar rats. J Bone Miner Res. 2003;18:2016-22. (Pubitemid 37377452)
4. Little DG, McDonald M, Sharpe IT, Peat R, Williams P, McEvoy T. Zoledronic acid improves femoral head sphericity in a rat model of Perthes disease. J Orthop Res. 2005;23:862-8. (Pubitemid 40960039)
5. Kim HK, Randall TS, Bian H, Jenkins J, Garces A, Bauss F. Ibandronate for prevention of femoral head deformity after ischemic necrosis of the capital femoral epiphysis in immature pigs. J Bone Joint Surg Am. 2005;87:550-7. (Pubitemid 40315005)
6. Kim HK, Sanders M, Athavale S, Bian H, Bauss F. Local bioavailability and distribution of systemically (parenterally) administered ibandronate in the infarcted femoral head. Bone. 2006;39:205-12. (Pubitemid 43831776)
7. Aya-ay J, Athavale S, Morgan-Bagley S, Bian H, Bauss F, Kim HK. Retention, distribution, and effects of intraosseously administered ibandronate in the infarcted femoral head. J Bone Miner Res. 2007;22:93-100. (Pubitemid 46032601)
8. Schmitt JM, Hwang K, Winn SR, Hollinger JO. Bone morphogenetic proteins: an update on basic biology and clinical relevance. J Orthop Res. 1999;17:269-78. (Pubitemid 29190501)
9. Valentin-Opran A, Wozney J, Csimma C, Lilly L, Riedel GE. Clinical evaluation of recombinant human bone morphogenetic protein-2. Clin Orthop Relat Res. 2002;395:110-20. (Pubitemid 34136661)
10. Kang P, Shen B, Yang J, Cheng J, Pei F. Repairing defect and preventing collapse of canine femoral head using titanium implant enhanced by autogenous bone graft and rhBMP-2. Connect Tissue Res. 2007;48:171-9. (Pubitemid 47189880)
11. Khosla S, Westendorf JJ, Oursler MJ. Building bone to reverse osteoporosis and repair fractures. J Clin Invest. 2008;118:421-8. (Pubitemid 351206529)
12. David L, Feige JJ, Bailly S. Emerging role of bone morphogenetic proteins in angiogenesis. Cytokine Growth Factor Rev. 2009;20:203-12.
13. Wang CK, Ho ML, Wang GJ, Chang JK, Chen CH, Fu YC, Fu HH. Controlledrelease of rhBMP-2 carriers in the regeneration of osteonecrotic bone. Biomaterials. 2009;30:4178-86.
14. Kim HK, Su PH. Development of flattening and apparent fragmentation following ischemic necrosis of the capital femoral epiphysis in a piglet model. J Bone Joint Surg Am. 2002;84:1329-34. (Pubitemid 35407576)
15. Pringle D, Koob TJ, Kim HK. Indentation properties of growing femoral head following ischemic necrosis. J Orthop Res. 2004;22:122-30. (Pubitemid 38035455)
16. Koob TJ, Pringle D, Gedbaw E, Meredith J, Berrios R, Kim HK. Biomechanical properties of bone and cartilage in growing femoral head following ischemic osteonecrosis. J Orthop Res. 2007;25:750-7. (Pubitemid 46831883)
17. Heyman CH, Herndon CH. Legg-Perthes disease; a method for the measurement of the roentgenographic result. J Bone Joint Surg Am. 1950;32:767-78.
18. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 1987;2:595-610.
19. Urist MR. Bone: formation by autoinduction. Science. 1965;150:893-9.
20. Itoh K, Udagawa N, Katagiri T, Iemura S, Ueno N, Yasuda H, Higashio K, Quinn JM, Gillespie MT, Martin TJ, Suda T, Takahashi N. Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand. Endocrinology. 2001;142:3656-62. (Pubitemid 32681777)
21. Kamiya N, Ye L, Kobayashi T, Lucas DJ, Mochida Y, Yamauchi M, Kronenberg HM, Feng JQ, Mishina Y. Disruption of BMP signaling in osteoblasts through type IA receptor (BMPRIA) increases bone mass. J Bone Miner Res. 2008;23:2007-17.
22. Kaneko H, Arakawa T, Mano H, Kaneda T, Ogasawara A, Nakagawa M, Toyama Y, Yabe Y, Kumegawa M, Hakeda Y. Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP receptors in mature osteoclasts. Bone. 2000;27:479-86.
23. Seeherman HJ, Li XJ, Bouxsein ML, Wozney JM. rhBMP-2 induces transient bone resorption followed by bone formation in a nonhuman primate core-defect model. J Bone Joint Surg Am. 2010;92:411-26.
24. Harding AK, Aspenberg P, Kataoka M, Bylski D, Tägil M. Manipulating the anabolic and catabolic response in bone graft remodeling: synergism by a combination of local BMP-7 and a single systemic dosis of zoledronate. J Orthop Res. 2008;26:1245-9.
25. Simank HG, Manggold J, Sebald W, Ries R, Richter W, Ewerbeck V, Sergi C. Bone morphogenetic protein-2 and growth and differentiation factor-5 enhance the healing of necrotic bone in a sheep model. Growth Factors. 2001;19:247-57. (Pubitemid 34071671)